In contrast to the pro-tumorigenic consequences of A3B overexpression, it has recently been shown that A3B overexpression can increase the sensitivity of tumor cells to immune checkpoint blockade therapy through an increase in the presentation of novel neoepitopes on the surface of cancer cells (27). The gene discussed is APOBEC3B; the disease is neoplasm.